Mannatech, Incorporated provides wellness solutions. The company develops, markets, and sells nutritional supplements, topical, skin care and anti-aging products, and weight-management products. It markets its products through network marketing channels in the Americas, Europe/the Middle East/Africa, and the Asia/Pacific. The company was founded in 1993 and is headquartered in Coppell, Texas.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MTEX
Previous Symbol
CUSIPN/A
Phone972-471-7400
Debt
Debt-to-Equity Ratio0.04
Current Ratio1.29
Quick Ratio0.94
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$176.70 million
Price / Sales0.26
Cash Flow$1.6560 per share
Price / Cash Flow11.70
Book Value$14.86 per share
Price / Book1.30
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-1,780,000.00
Net Margins-3.43%
Return on Equity-2.51%
Return on Assets-1.19%
Miscellaneous
Employees252
Outstanding Shares2,380,000
Market Cap$45.46 million
OptionableNot Optionable
Mannatech (NASDAQ:MTEX) Frequently Asked Questions
What is Mannatech's stock symbol?
Mannatech trades on the NASDAQ under the ticker symbol "MTEX."
How often does Mannatech pay dividends? What is the dividend yield for Mannatech?
Mannatech announced a quarterly dividend on Wednesday, November 14th. Shareholders of record on Thursday, December 6th will be paid a dividend of $0.50 per share on Thursday, December 27th. This represents a $2.00 dividend on an annualized basis and a yield of 10.32%. The ex-dividend date is Wednesday, December 5th. View Mannatech's Dividend History.
How will Mannatech's stock buyback program work?
Mannatech announced that its board has authorized a share buyback plan on Wednesday, November 14th 2018, which permits the company to buyback $500,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 1.3% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board believes its stock is undervalued.
How were Mannatech's earnings last quarter?
Mannatech, Inc. (NASDAQ:MTEX) announced its earnings results on Tuesday, November, 6th. The company reported ($0.69) EPS for the quarter. The firm had revenue of $43.01 million for the quarter. Mannatech had a negative net margin of 3.43% and a negative return on equity of 2.51%. View Mannatech's Earnings History.
When is Mannatech's next earnings date?
Has Mannatech been receiving favorable news coverage?
Press coverage about MTEX stock has trended somewhat positive on Monday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Mannatech earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are some of Mannatech's key competitors?
Some companies that are related to Mannatech include Chromadex (CDXC), Mediwound (MDWD), Natural Alternatives International (NAII), China Jo-Jo Drugstores (CJJD), Pharmacyte Biotech (PMCB), GLG Life Tech (GLGLF), Cyanotech (CYAN), FitLife Brands (FTLF), Tauriga Sciences (TAUG), True Drinks (TRUU), Nutra Pharma (NPHC), Entia Biosciences (ERGO), Rock Creek Pharmaceuticals (RCPIQ), Beleave (BE) and Beleave (BE).
Who are Mannatech's key executives?
Mannatech's management team includes the folowing people:
- Mr. Alfredo Bala, CEO & Pres (Age 57)
- Mr. Joel R. Bikman, Chief Operating & Marketing Officer (Age 45)
- Mr. Yong Jae Park, Regional Pres of Asia (Age 50)
- Mr. David A. Johnson, Chief Financial Officer (Age 48)
- Ms. Erin Kemmler Barta, Gen. Counsel & Corp. Sec. (Age 48)
Who are Mannatech's major shareholders?
Mannatech's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (3.54%) and Renaissance Technologies LLC (0.49%). Company insiders that own Mannatech stock include Alfredo Bala, Eric W Schrier, Kevin Andrew Robbins, Larry A Jobe, Linda K Ferrell and Robert Toth. View Institutional Ownership Trends for Mannatech.
Which major investors are selling Mannatech stock?
Which major investors are buying Mannatech stock?
MTEX stock was bought by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP. Company insiders that have bought Mannatech stock in the last two years include Eric W Schrier, Kevin Andrew Robbins, Larry A Jobe, Linda K Ferrell and Robert Toth. View Insider Buying and Selling for Mannatech.
How do I buy shares of Mannatech?
Shares of MTEX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Mannatech's stock price today?
One share of MTEX stock can currently be purchased for approximately $19.3750.
How big of a company is Mannatech?
Mannatech has a market capitalization of $45.46 million and generates $176.70 million in revenue each year. Mannatech employs 252 workers across the globe.
What is Mannatech's official website?
How can I contact Mannatech?
Mannatech's mailing address is 1410 LAKESIDE PARKWAY SUITE 200, FLOWER MOUND TX, 75028. The company can be reached via phone at 972-471-7400 or via email at [email protected]
MarketBeat Community Rating for Mannatech (NASDAQ MTEX)
MarketBeat's community ratings are surveys of what our community members think about Mannatech and other stocks. Vote "Outperform" if you believe MTEX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTEX will underperform the S&P 500 over the long term. You may vote once every thirty days.
